Form 4: Sanara MedTech CEO Ronald T. Nixon Reports Stock Grant and Beneficial Ownership Changes
SEC Form 4 Filing
Ronald T. Nixon, CEO of Sanara MedTech Inc., reports acquisition of restricted stock and details of beneficial ownership through related entities.
Summary
- Ronald T. Nixon, CEO of Sanara MedTech Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
- He acquired 7,534 shares of restricted stock on February 25, 2025, granted under the company's 2024 Omnibus Long-Term Incentive Plan.
- These shares will vest in three equal installments on February 25, 2026, 2027, and 2028.
- Nixon also reported indirect ownership of 2,452,731 shares through CGI Cellerate RX, LLC and 963,856 shares through FA Sanara, LLC.
- He disclaims beneficial ownership of these indirectly held shares except to the extent of his pecuniary interests.
Sentiment
Score: 6
Explanation: The document is a standard SEC filing, indicating routine transactions. The sentiment is neutral as it simply reports facts without expressing positive or negative views.
Positives
- The grant of restricted stock to the CEO aligns his interests with the long-term performance of the company.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. This filing indicates changes in the CEO's holdings of Sanara MedTech stock.
Stakeholder Impact
- The stock grant could be viewed positively by shareholders as it aligns management's interests with the company's long-term success.
Key Dates
| Date | Description |
|---|---|
| 02/25/2025 | Date of transaction: Acquisition of restricted stock. |
| 02/25/2026 | First vesting date for restricted stock (one-third). |
| 02/25/2027 | Second vesting date for restricted stock (one-third). |
| 02/25/2028 | Final vesting date for restricted stock (one-third). |
| 02/27/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.